Detalles de la búsqueda
1.
The Fatal Clinical Outcome of Severe COVID-19 in Hospitalized Patients: Findings from a Prospective Cohort Study in Dhaka, Bangladesh.
Medicina (Kaunas)
; 59(7)2023 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37512091
2.
Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants.
mSphere
; 9(3): e0056523, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38391226
3.
A snap-shot of a diarrheal epidemic in Dhaka due to enterotoxigenic Escherichia coli and Vibrio cholerae O1 in 2022.
Front Public Health
; 11: 1132927, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37124777
4.
Determining clinical biomarkers to predict long-term SARS-CoV-2 antibody response among COVID-19 patients in Bangladesh.
Front Med (Lausanne)
; 10: 1111037, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37293303
5.
Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations.
Front Immunol
; 14: 1309997, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38173725
6.
Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh.
Front Immunol
; 13: 929849, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36248882
7.
Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh.
Front Immunol
; 13: 1067737, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36618409
8.
A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.
Vaccine
; 40(4): 640-649, 2022 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34969541
9.
Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh.
Front Immunol
; 13: 1052374, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36578502
10.
Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh.
PLoS Negl Trop Dis
; 16(1): e0010102, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34982773
11.
Measuring the Effectiveness of COVID-19 Vaccines Used during a Surge of the Delta Variant of SARS-CoV-2 in Bangladesh: A Test-Negative Design Evaluation.
Vaccines (Basel)
; 10(12)2022 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36560479
12.
A non-inferiority trial comparing two recombinant vaccines (Hepa-B vs. Engerix-B) for hepatitis B among adults in Dhaka, Bangladesh.
Vaccine
; 39(43): 6385-6390, 2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34561142
13.
A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.
Vaccine
; 39(32): 4450-4457, 2021 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34218960
14.
Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh.
PLoS Negl Trop Dis
; 14(3): e0007989, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32176695
15.
Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine.
Vaccine
; 38(7): 1753-1761, 2020 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879124
Resultados
1 -
15
de 15
1
Próxima >
>>